Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7919514 Thiadiazole compounds and methods of use

Patent 7919514 was granted and assigned to Amgen on April, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Holger Monenschein0

James Thomas Rider0

Qingping Zeng0

Guomin Yao0

Date of Patent

April 5, 2011

0

Patent Application Number

120776330

Date Filed

March 19, 2008

0

Patent Citations Received

US Patent 12083121 Substituted piperazines as KRAS G12C inhibitors

0

US Patent 11766436 KRAS G12C inhibitors and methods of using the same

US Patent 11905281 KRAS G12C inhibitors and methods of using the same

0

US Patent 11918584 Combination therapy including a KRAS

0

US Patent 11964971 Methods and compositions for modulating splicing

0

US Patent 11993597 Inhibitors of KRAS G12C and methods of using the same

0

Patent Primary Examiner

Golam M. Shameem

0

Patent abstract

The invention relates to thiadiazole compounds useful for treating diseases mediated by protein kinase B (PKB). The invention also relates to the therapeutic use of such thiadiazole compounds and compositions thereof in treating disease states associated with abnormal cell growth, cancer, inflammation, and metabolic disorders.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7919514 Thiadiazole compounds and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool